Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat

Manika Das1, Joanne E Parker, Andrew P Halestrap

  • 1Department of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.

The Journal of Physiology
|February 4, 2003
PubMed

Insights

This study challenges the existence of the mitochondrial ATP-sensitive potassium channel (mitoKATP). Researchers found no evidence supporting its role in mitochondrial function or response to common modulators.

Area of Science:

  • Mitochondrial Physiology
  • Cellular Signaling
  • Biophysics

Background:

  • The mitochondrial ATP-sensitive potassium channel (mitoKATP) is proposed to be involved in ischemic preconditioning.
  • This channel is reportedly inhibited by 5-hydroxydecanoate (5-HD) and activated by diazoxide.

Purpose of the Study:

  • To re-evaluate the evidence for the existence of the mitoKATP channel.
  • To investigate the effects of ATP, ADP, and specific channel modulators on mitochondrial volume and light scattering.

Main Methods:

  • Measurement of light scattering (A520) in isolated rat liver and heart mitochondria.
  • Direct determination of mitochondrial matrix volumes using 3H2O and [14C]sucrose.
  • Assessment of adenine nucleotide translocase (ANT) activity using specific inhibitors (carboxyatractyloside, bongkrekic acid).

Main Results:

  • ATP and ADP induced changes in light scattering, but not matrix volume, suggesting effects on mitochondrial shape via ANT.
  • Neither diazoxide nor 5-HD produced expected changes in light scattering or matrix volume.
  • Valinomycin caused a detectable increase in matrix volume, serving as a positive control.

Conclusions:

  • The data argue against the existence of a sulphonylurea-inhibitable mitoKATP channel.
  • Observed effects of ATP/ADP on light scattering are attributed to conformational changes in the ANT, not mitoKATP activity.
  • The proposed role of mitoKATP in ischemic preconditioning requires re-evaluation.

Related Concept Videos